RDY
Dr. Reddy's Laboratories Ltd. Earnings
$14.59
Earnings Summary
Revenue | $88051Mn |
Net Profits | $14372Mn |
Net Profit Margins | 16.32% |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 9.84% since last year same period to $88051Mn in the Q3 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 3.04% jump in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit jumped 14.49% since last year same period to $14372Mn in the Q3 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 1.37% jump in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin jumped 4.23% since last year same period to 16.32% in the Q3 2025. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated -1.62% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 18.31 |
EPS Estimate Current Year | 18.31 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 18.31 - a 8619.05% jump from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 18.31.
Key Ratios
Earning Per Share (EPS) | 0 |
Dividend Per Share (DPS) | 0.19 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Dr. Reddy's Laboratories Ltd. declared 0.19 dividend per share during the earnings announcement for Q3 2025.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-06-30 | 0.21 | 0.2 | -4.76% |
2025-06-06 | 17.13 | 19.11 | 11.56% |
2025-10-24 | 18.31 | 0 | -100% |
